AU5668286A - Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use - Google Patents

Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use

Info

Publication number
AU5668286A
AU5668286A AU56682/86A AU5668286A AU5668286A AU 5668286 A AU5668286 A AU 5668286A AU 56682/86 A AU56682/86 A AU 56682/86A AU 5668286 A AU5668286 A AU 5668286A AU 5668286 A AU5668286 A AU 5668286A
Authority
AU
Australia
Prior art keywords
therapeutic
compositions
methods
carbohydrate derivatives
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56682/86A
Other languages
English (en)
Inventor
Elisabeth Kallin
Frank Lindh
Hans Lonn
Olle Mansson
Per Anders Mardh
Bo Nilsson
Sigfrid Svensson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocarb AB
Original Assignee
Biocarb AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocarb AB filed Critical Biocarb AB
Publication of AU5668286A publication Critical patent/AU5668286A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU56682/86A 1985-04-01 1986-03-25 Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use Abandoned AU5668286A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8501613 1985-04-01
SE8501613A SE8501613D0 (sv) 1985-04-01 1985-04-01 Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Publications (1)

Publication Number Publication Date
AU5668286A true AU5668286A (en) 1986-10-23

Family

ID=20359733

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56682/86A Abandoned AU5668286A (en) 1985-04-01 1986-03-25 Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use

Country Status (4)

Country Link
EP (1) EP0217912A1 (fr)
AU (1) AU5668286A (fr)
SE (1) SE8501613D0 (fr)
WO (1) WO1986005789A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582758B2 (en) * 1984-06-28 1989-04-13 Mect Corporation Sialic acid derivatives, galactose derivatives and method for producing the same

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640628A1 (fr) * 1988-12-16 1990-06-22 Commissariat Energie Atomique Oligosaccharides lies (beta)-(1 -> 6) en particulier des 2-acetamido-2-desoxy-glucoses ou - galactoses et leur preparation
FR2645741B1 (fr) * 1989-03-20 1995-06-23 Dior Christian Parfums Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation
FR2663636B1 (fr) * 1990-06-26 1992-10-09 Centre Nat Rech Scient Procede de fonctionnalisation d'un oligonucleotide.
DE69110906T2 (de) * 1990-12-21 1995-11-16 Microcarb Inc Verwendung von Wirtszellphospholipiden zur Hemmung bakterieller Besiedlung.
CA2114629C (fr) * 1991-07-31 2003-01-14 Howard C. Krivan Conjugues a recepteurs pour le ciblage d'antibiotiques a des bacteries
JP2894879B2 (ja) * 1991-10-04 1999-05-24 日本メジフィジックス株式会社 診断用造影剤
NZ536331A (en) 2002-05-09 2007-08-31 Hemoteq Ag Compounds and method for coating surfaces of medical devices such as stents in a haemocompatible manner
DE10261986B4 (de) * 2002-05-10 2008-01-31 Hemoteq Ag Hämokompatibel beschichtete Oberflächen, Verfahren zu deren Herstellung und deren Verwendungen
WO2013051597A1 (fr) 2011-10-04 2013-04-11 塩野義製薬株式会社 Dérivé céphem ayant un groupe catéchol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155575A (en) * 1960-12-16 1964-11-03 Warner Lambert Pharmaceutical Composition for inhibiting pepsin activity and method of preparing same
US3632754A (en) * 1968-02-12 1972-01-04 Lescarden Ltd Use of chitin for promoting wound healing
US3911116A (en) * 1970-04-13 1975-10-07 Leslie L Balassa Process for promoting wound healing with chitin derivatives
US3914413A (en) * 1971-02-10 1975-10-21 Leslie L Balassa Process for facilitating wound healing with N-acetylated partially depolymerized chitin materials
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
SE8301609D0 (sv) * 1983-03-23 1983-03-23 Svenska Sockerfabriks Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
DE3347163A1 (de) * 1983-12-27 1985-07-04 Behringwerke Ag, 3550 Marburg Verwendung von oligosacchariden zur chemotherapie oder chemoprophylaxe der malaria
DE3402739A1 (de) * 1984-01-27 1985-08-01 Boehringer Ingelheim Diagnostika GmbH, 8046 Garching Antikoerper gegen den glycanstrang des peptidoglycans, verfahren und reagenzien zu ihrer herstellung und methoden zu ihrer quantitativen bestimmung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582758B2 (en) * 1984-06-28 1989-04-13 Mect Corporation Sialic acid derivatives, galactose derivatives and method for producing the same

Also Published As

Publication number Publication date
SE8501613D0 (sv) 1985-04-01
WO1986005789A1 (fr) 1986-10-09
EP0217912A1 (fr) 1987-04-15

Similar Documents

Publication Publication Date Title
AU588857B2 (en) Thiazolidine derivatives, their preparation and use
AU589371B2 (en) Purine derivatives and use as therapeutic agent
HK125993A (en) Piperidine derivative,its preparation,and its use as medicament
AU7766787A (en) Arylcarboxylic acid derivatives, the preparation and use thereof
IL88765A (en) N-hydroxycycloalkyl or n-hydroxycycloalkenyl- substituted adenosine derivatives, methods for their preparation and pharmaceutical compositions, including antilipolytic compositions, containing the same
AU7670287A (en) Computer tomographic phantom
AU545727B2 (en) Phosphate derivatives and fillers for human hard tissues containing the same
AU3072989A (en) Skin treatment composition
AU582113B2 (en) Furo-(3,4-C)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
AU1907788A (en) N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy
AU3892593A (en) Composition for therapeutic or diagnostic use, process for its preparation and its use
AU3480884A (en) Rachioscoliosis medical examination
AU7806387A (en) Connection preferably for medical use
AU8316587A (en) Pharmaceutical compositions and their use
AU4705185A (en) Medical device, its preparation and use
AU5668286A (en) Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use
AU6203086A (en) Azolyl-cyclopropyl-ethanol derivatives, processes for their preparation and their use
AU618865B2 (en) Adenosin derivatives, their preparation and use
ZA879235B (en) Peridone derivatives,and their preparation and use
AU578739B2 (en) Vinyltetrazolylphenyl derivatives, their preparation and their use
AU1450788A (en) Thiophene-2-carbox-amide derivatives and their pharmaceutical use
AU581956B2 (en) 6-chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepine- N-oxide and medical compositions using it
AU4266089A (en) 3-aryloxymethyl-cephalosporin derivatives, their preparation and their medical use
AU8129987A (en) Pyrrolo-benzimidazoles, their preparation and use
ZA852632B (en) Perhydrothiazepine derivatives,their preparation and their therapeutic use